Clinical Study
Study of Feasibility and Safety of Higher-Dose Dexmedetomidine in Special Outpatient Examination of Pediatric Ophthalmology
Table 3
Vital signs in different stages between 2 μg/kg and 3 μg/kg groups.
| Group | 2 μg/kg group () | 3 μg/kg group () | value |
| Heart rate | Presedation | 123.0 ± 8.8 | 121.8 ± 9.6 | 0.545 | Onset | 110.7 ± 10.0 | 93.2 ± 7.7 | <0.001 | Examination | 108.4 ± 6.6 | 96.2 ± 6.7 | <0.001 | Recovery | 121.0 ± 11.0 | 102.1 ± 8.2 | <0.001 |
| SpO2 | Presedation | 98.8 ± 0.7 | 98.8 ± 0.7 | 0.851 | Onset | 97.6 ± 0.8 | 97.3 ± 0.7 | 0.072 | Examination | 97.38 ± 1.03 | 96.92 ± 1.03 | 0.014 | Recovery | 98.38 ± 1.05 | 97.98 ± 1.41 | 0.230 |
| Mean arterial pressure | Onset | 83.22 ± 1.91 | 80.84 ± 3.15 | <0.001 | Examination | 83.22 ± 1.91 | 81.70 ± 2.52 | 0.001 | Recovery | 83.22 ± 1.91 | 82.84 ± 1.89 | 0.308 |
|
|